Orthopedics News and Research RSS Feed - Orthopedics News and Research

FDA Grants clearance to MXO's dynaMX Compression Staple featuring Malleable Nitinol Technology

FDA Grants clearance to MXO's dynaMX Compression Staple featuring Malleable Nitinol Technology

MX Orthopedics, Corp., a leader in superelastic technologies for orthopedic implants, announces the recent FDA clearance (K143622) of its patent-pending dynaMX™ Compression Staple featuring Malleable Nitinol Technology. [More]
PROMISSE study: Most women with lupus can expect good pregnancy outcomes

PROMISSE study: Most women with lupus can expect good pregnancy outcomes

One of the most important and anxiety-producing concerns among patients with lupus is whether it is safe to become pregnant. A pioneering study led by researchers at Hospital for Special Surgery has shown that most women can expect a good pregnancy outcome if their lupus is inactive and they are free of certain risk factors. [More]
The Miriam Hospital offers new surgical treatment for benign prostatic hyperplasia

The Miriam Hospital offers new surgical treatment for benign prostatic hyperplasia

The Minimally Invasive Urology Institute at The Miriam Hospital is offering UroLift as one of the newest surgical treatments available for men with benign prostatic hyperplasia (BPH), an enlarged prostate condition. [More]
New multidisciplinary Centre For Research into Obesity and Related Diseases opens In Sao Paulo

New multidisciplinary Centre For Research into Obesity and Related Diseases opens In Sao Paulo

Researchers, clinicians, health educators and policy makers all gathered on May 4th in Sao Paulo, Brazil, as the new Multidisciplinary Centre for Research into Obesity and Related Comorbidities (Cepid-OCRC) was opened at da Universidade Estadual de Campinas (UNICAMP). [More]
Lilly, Sarah Cannon Research Institute partner to co‑develop investigational oncology compound

Lilly, Sarah Cannon Research Institute partner to co‑develop investigational oncology compound

Eli Lilly and Company and Sarah Cannon Research Institute today announced a strategic partnership to co‑develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor. Under the agreement, SCRI will collaborate with Lilly to provide clinical development expertise and program design, as well as medical oversight and trial management. Patient enrollment for the initial Phase II clinical trial is underway. [More]
CyMedica Orthopedics closes $11.5 million Series A financing

CyMedica Orthopedics closes $11.5 million Series A financing

CyMedica Orthopedics, Inc. announced today that it has closed an extension to its Series A financing. The Series A financing was led by investors Research Corporation Technologies, Inc., a Tucson-based venture capital firm, and California Technology Ventures, LLC, a Pasadena-based venture capital fund. The financing also included participation from existing investor Aphelion Capital (Mill Valley, CA) and the founding group of investors. [More]
Six physician organizations in Sutter Medical Network receive 'Elite' status

Six physician organizations in Sutter Medical Network receive 'Elite' status

Six physician organizations in the Sutter Medical Network, including all five medical foundations, received "Elite" status today in the annual CAPG Standards of Excellence Survey—the highest possible honor awarded by the CAPG professional organization. [More]
Griffith student finds success in medical tourism

Griffith student finds success in medical tourism

The world of medical tourism was not one that Dan Donner had ever considered as a potential career path, but today he can be found dividing his time between study at Griffith University and running a flourishing business in Thailand. [More]
El Camino Hospital enrolls first patient in safety study using RenovoCath

El Camino Hospital enrolls first patient in safety study using RenovoCath

El Camino Hospital in Mountain View, California has enrolled the first patient in a safety study using the RenovoCath, a new catheter that is being introduced for targeted delivery of fluids to selected sites in the peripheral vascular system. The study will help physicians determine appropriate dosing of locally-delivered chemotherapy for patients with pancreatic cancer. [More]
North American Spine Society issues formal coverage recommendation for MIS SI joint fusion

North American Spine Society issues formal coverage recommendation for MIS SI joint fusion

SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System®, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that the North American Spine Society (NASS) has issued their formal coverage recommendation for MIS SI joint fusion titled "Percutaneous Sacroiliac Joint Fusion, Defining Appropriate Coverage Positions." [More]
Twin Cities Orthopedics joins Deterra partnership program to reduce prescription drug abuse and misuse

Twin Cities Orthopedics joins Deterra partnership program to reduce prescription drug abuse and misuse

Verde Technologies announced that Golden Valley-based Twin Cities Orthopedics, the largest orthopedic group in Minnesota, has become its most recent partner in the fight against prescription drug abuse and misuse. [More]
Short course of oral steroids unlikely to provide much benefit for patients with acute sciatica

Short course of oral steroids unlikely to provide much benefit for patients with acute sciatica

Among patients with acute sciatica caused by a herniated lumbar disk (a condition also known as "acute radiculopathy"), a short course of oral steroids resulted in only modest improvement in function and no significant improvement in pain, according to a study published today in the Journal of the American Medical Association. [More]
Boehringer Ingelheim, Sutter Health announce health care innovation collaboration

Boehringer Ingelheim, Sutter Health announce health care innovation collaboration

Boehringer Ingelheim, a family-owned biopharmaceutical company, and Sutter Health, a not-for-profit health system in Northern California, today announced the start of a five-year research and health care innovation collaboration, which will explore and test the value of digital health solutions, mobile technologies, and insights from advanced data analytics in the delivery of health care. [More]
DePuy Synthes, Stryker, Zimmer and Medtronic dominate global orthopedic device market

DePuy Synthes, Stryker, Zimmer and Medtronic dominate global orthopedic device market

Kalorama Information said that four companies, including DePuy Synthes, Stryker, Zimmer and Medtronic, lead the Orthopedic Device Market. These four device firms captured approximately 70.4% of total revenues for 2014 for the global orthopedic device market. [More]
The Valley Hospital receives A grade for patient safety in seven consecutive score reports

The Valley Hospital receives A grade for patient safety in seven consecutive score reports

For the seventh consecutive time, The Valley Hospital in Ridgewood, NJ, has been recognized for its dedication to patient safety by being awarded an A grade in the Spring 2015 Hospital Safety Score, which rates how well hospitals protect patients from preventable medical errors, injuries and infections within the hospital. [More]
CyMedica QB1 System now commercially available for treatment of quadriceps muscle atrophy

CyMedica QB1 System now commercially available for treatment of quadriceps muscle atrophy

Scottsdale-based CyMedica Orthopedics, Inc. announced the commercial launch of the CyMedica QB1 System for the treatment of quadriceps muscle atrophy at the Arthroscopy Association of North American Arthroscopic Society for Sports Medicine annual meeting in Los Angeles last week. [More]
UI orthopedics researchers working on injectable, bioactive gel that can repair cartilage damage

UI orthopedics researchers working on injectable, bioactive gel that can repair cartilage damage

Knee injuries are the bane of athletes everywhere, from professionals and college stars to weekend warriors. Current surgical options for repairing damaged cartilage caused by knee injuries are costly, can have complications, and often are not very effective in the long run. Even after surgery, cartilage degeneration can progress leading to painful arthritis. [More]
Miriam Hospital awarded BDC designation for bariatric surgery

Miriam Hospital awarded BDC designation for bariatric surgery

Blue Cross Blue Shield of Rhode Island has awarded The Miriam Hospital a Blue Distinction Center+ (BDC) designation for bariatric surgery. A designation by the Blue Distinction Centers for Specialty Care program, BDCs are nationally designated health care facilities that deliver quality specialty care based on objective measures for patient safety and better health outcomes. [More]
OSU study finds that injury prevention programs are not being used in high schools

OSU study finds that injury prevention programs are not being used in high schools

Injury prevention programs can help reduce ankle, knee and other lower extremity injuries in sports, but the programs are not being widely used in high schools, a new study from Oregon State University has found. [More]
Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Jersey Shore has earned The Joint Commission's Gold Seal of Approval for its Hip and Knee Joint Replacement Program by demonstrating compliance with The Joint Commission's national standards for health care quality and safety in disease-specific care. The certification award recognizes the hospital's dedication to continuous compliance with The Joint Commission's rigorous standards. [More]
Advertisement
Advertisement